Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric.

Similar presentations


Presentation on theme: "Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric."— Presentation transcript:

1 Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial  Etienne G.C. Brain, Cécile Mertens, Véronique Girre, Frédérique Rousseau, Emmanuel Blot, Sophie Abadie, Lionel Uwer, Emmanuelle Bourbouloux, Isabelle Van Praagh-Doreau, Loic Mourey, Sylvie Kirscher, Brigitte Laguerre, Emmanuelle Fourme, Sylvia Luneau, Jean Genève, Marc Debled  Critical Reviews in Oncology / Hematology  Volume 80, Issue 1, Pages (October 2011) DOI: /j.critrevonc Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

2 Fig. 1 Changes in the ADL scores during treatment. Legend: ADL, Katz Activities of daily living; CT, chemotherapy; C3, cycle 3. Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc ) Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions


Download ppt "Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric."

Similar presentations


Ads by Google